Cargando…

Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis

Background: Big data and real-world data (RWD) have been increasingly used to measure the effectiveness and costs in cost-effectiveness analysis (CEA). However, the characteristics and methodologies of CEA based on big data and RWD remain unknown. The objectives of this study were to review the char...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Z. Kevin, Xiong, Xiaomo, Lee, Taiying, Wu, Jun, Yuan, Jing, Jiang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562301/
https://www.ncbi.nlm.nih.gov/pubmed/34737696
http://dx.doi.org/10.3389/fphar.2021.700012
_version_ 1784593235683835904
author Lu, Z. Kevin
Xiong, Xiaomo
Lee, Taiying
Wu, Jun
Yuan, Jing
Jiang, Bin
author_facet Lu, Z. Kevin
Xiong, Xiaomo
Lee, Taiying
Wu, Jun
Yuan, Jing
Jiang, Bin
author_sort Lu, Z. Kevin
collection PubMed
description Background: Big data and real-world data (RWD) have been increasingly used to measure the effectiveness and costs in cost-effectiveness analysis (CEA). However, the characteristics and methodologies of CEA based on big data and RWD remain unknown. The objectives of this study were to review the characteristics and methodologies of the CEA studies based on big data and RWD and to compare the characteristics and methodologies between the CEA studies with or without decision-analytic models. Methods: The literature search was conducted in Medline (Pubmed), Embase, Web of Science, and Cochrane Library (as of June 2020). Full CEA studies with an incremental analysis that used big data and RWD for both effectiveness and costs written in English were included. There were no restrictions regarding publication date. Results: 70 studies on CEA using RWD (37 with decision-analytic models and 33 without) were included. The majority of the studies were published between 2011 and 2020, and the number of CEA based on RWD has been increasing over the years. Few CEA studies used big data. Pharmacological interventions were the most frequently studied intervention, and they were more frequently evaluated by the studies without decision-analytic models, while those with the model focused on treatment regimen. Compared to CEA studies using decision-analytic models, both effectiveness and costs of those using the model were more likely to be obtained from literature review. All the studies using decision-analytic models included sensitivity analyses, while four studies no using the model neither used sensitivity analysis nor controlled for confounders. Conclusion: The review shows that RWD has been increasingly applied in conducting the cost-effectiveness analysis. However, few CEA studies are based on big data. In future CEA studies using big data and RWD, it is encouraged to control confounders and to discount in long-term research when decision-analytic models are not used.
format Online
Article
Text
id pubmed-8562301
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85623012021-11-03 Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis Lu, Z. Kevin Xiong, Xiaomo Lee, Taiying Wu, Jun Yuan, Jing Jiang, Bin Front Pharmacol Pharmacology Background: Big data and real-world data (RWD) have been increasingly used to measure the effectiveness and costs in cost-effectiveness analysis (CEA). However, the characteristics and methodologies of CEA based on big data and RWD remain unknown. The objectives of this study were to review the characteristics and methodologies of the CEA studies based on big data and RWD and to compare the characteristics and methodologies between the CEA studies with or without decision-analytic models. Methods: The literature search was conducted in Medline (Pubmed), Embase, Web of Science, and Cochrane Library (as of June 2020). Full CEA studies with an incremental analysis that used big data and RWD for both effectiveness and costs written in English were included. There were no restrictions regarding publication date. Results: 70 studies on CEA using RWD (37 with decision-analytic models and 33 without) were included. The majority of the studies were published between 2011 and 2020, and the number of CEA based on RWD has been increasing over the years. Few CEA studies used big data. Pharmacological interventions were the most frequently studied intervention, and they were more frequently evaluated by the studies without decision-analytic models, while those with the model focused on treatment regimen. Compared to CEA studies using decision-analytic models, both effectiveness and costs of those using the model were more likely to be obtained from literature review. All the studies using decision-analytic models included sensitivity analyses, while four studies no using the model neither used sensitivity analysis nor controlled for confounders. Conclusion: The review shows that RWD has been increasingly applied in conducting the cost-effectiveness analysis. However, few CEA studies are based on big data. In future CEA studies using big data and RWD, it is encouraged to control confounders and to discount in long-term research when decision-analytic models are not used. Frontiers Media S.A. 2021-10-19 /pmc/articles/PMC8562301/ /pubmed/34737696 http://dx.doi.org/10.3389/fphar.2021.700012 Text en Copyright © 2021 Lu, Xiong, Lee, Wu, Yuan and Jiang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Lu, Z. Kevin
Xiong, Xiaomo
Lee, Taiying
Wu, Jun
Yuan, Jing
Jiang, Bin
Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis
title Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis
title_full Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis
title_fullStr Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis
title_full_unstemmed Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis
title_short Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis
title_sort big data and real-world data based cost-effectiveness studies and decision-making models: a systematic review and analysis
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562301/
https://www.ncbi.nlm.nih.gov/pubmed/34737696
http://dx.doi.org/10.3389/fphar.2021.700012
work_keys_str_mv AT luzkevin bigdataandrealworlddatabasedcosteffectivenessstudiesanddecisionmakingmodelsasystematicreviewandanalysis
AT xiongxiaomo bigdataandrealworlddatabasedcosteffectivenessstudiesanddecisionmakingmodelsasystematicreviewandanalysis
AT leetaiying bigdataandrealworlddatabasedcosteffectivenessstudiesanddecisionmakingmodelsasystematicreviewandanalysis
AT wujun bigdataandrealworlddatabasedcosteffectivenessstudiesanddecisionmakingmodelsasystematicreviewandanalysis
AT yuanjing bigdataandrealworlddatabasedcosteffectivenessstudiesanddecisionmakingmodelsasystematicreviewandanalysis
AT jiangbin bigdataandrealworlddatabasedcosteffectivenessstudiesanddecisionmakingmodelsasystematicreviewandanalysis